Arthur Fratamico
Directeur/Membre du Conseil chez PANBELA THERAPEUTICS, INC.
Fortune : - $ au 30/06/2024
Profil
Arthur J.
Fratamico is currently the President & Chief Executive Officer at Radiant Biotherapeutics, Inc. since 2021 and an Independent Director at Panbela Therapeutics, Inc. since 2019.
Previously, he held positions as Vice President-Business Development & Licensing at MGI PHARMA, Inc., Chief Business Officer at Flexion Therapeutics, Inc. from 2012 to 2014, Chief Business Officer at Vitae Pharmaceuticals LLC from 2014 to 2016, Vice President-Business & Strategic Development at Gemin X Pharmaceuticals US, Inc. from 2009 to 2010, and Principal at Hoechst Marion Roussel, Inc. He also served as the Chief Business Officer at Trevena, Inc. and Galera Therapeutics, Inc. Mr. Fratamico holds an MBA from Drexel University and an undergraduate degree from Philadelphia College of Pharmacy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PANBELA THERAPEUTICS INC
-.--% | 24/04/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Arthur Fratamico
| Sociétés | Poste | Début |
|---|---|---|
| PANBELA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/12/2019 |
Radiant Biotherapeutics, Inc.
 Radiant Biotherapeutics, Inc. BiotechnologyHealth Technology Radiant Biotherapeutics, Inc. develops multi-valent and specific bio therapeutics solutions. Arthur J. Fratamico has been the CEO of the Canadian company since 2021. | Directeur Général | 01/05/2021 |
Anciens postes connus de Arthur Fratamico
| Sociétés | Poste | Fin |
|---|---|---|
| VITAE PHARMACEUTICALS INC | Corporate Officer/Principal | 25/12/2016 |
| FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2014 |
| GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| TREVENA, INC. | Corporate Officer/Principal | - |
| Hoechst Marion Roussel, Inc. | Corporate Officer/Principal | - |
Formation de Arthur Fratamico
| Drexel University | Masters Business Admin |
| Philadelphia College of Pharmacy | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GALERA THERAPEUTICS, INC. | Health Technology |
| TREVENA, INC. | Health Technology |
| PANBELA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
| Hoechst Marion Roussel, Inc. | |
Radiant Biotherapeutics, Inc.
Radiant Biotherapeutics, Inc. BiotechnologyHealth Technology Radiant Biotherapeutics, Inc. develops multi-valent and specific bio therapeutics solutions. Arthur J. Fratamico has been the CEO of the Canadian company since 2021. | Health Technology |
